News Agency
Men's Weekly

D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline

  • Written by PR Newswire
D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline

SHANGHAI, April 8, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs announces its closing of Series A+ financing round led by Medicxi, a leading European life sciences investment firm. D3 Bio's existing investors, Matrix Partners China and...

Read more: D3 Bio Completes Series A+ Round to Advance Innovative Oncology Pipeline

Gender-Inclusive Lash Treatments: Breaking Beauty Norms

Beauty is no longer defined by traditional gender standards, and the lash industry is evolving to reflect that.  In 2026, more clients of all genders are seeking lash lifts, tints, and extensions that enhance their natural features while respecting individual style... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion